Company intelligence / Profile preview

Diet Max Sigma

Quesna, Menofia, Egypt
Ownership
Private
Development stage
Other
01

Overview

Sigma Pharmaceutical Industries is a prominent Egyptian pharmaceutical company founded in 1997 by Dr. El-Sayed El-Badawi. Headquartered in Quesna, Egypt, the company is a major manufacturer of generic medications, specializing in therapeutic areas such as metabolic disorders, respiratory health, and gastroenterology. It is widely recognized for its weight loss brand Diet Max (historically containing sibutramine) and other prominent Egyptian brands like Congestal and Aciloc. Sigma operates advanced manufacturing facilities, including the Sigmatec plant in 6th of October City, and has a significant presence across the Middle East and North Africa (MENA) region through various subsidiaries. The company focuses on delivering high-quality, affordable healthcare solutions and continues to expand its regional footprint through strategic acquisitions and partnerships.

Therapeutic areas
EndocrinologyCardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
Modalities
Small molecule
Industry
Biotech
02

Partnerships

Eastgate Capital GroupSPIMACO

Beyond the preview

Go deeper on Diet Max Sigma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diet Max Sigma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call